80 related articles for article (PubMed ID: 2804985)
21. Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity.
Parac-Vogt TN; Kimpe K; Laurent S; Vander Elst L; Burtea C; Chen F; Muller RN; Ni Y; Verbruggen A; Binnemans K
Chemistry; 2005 May; 11(10):3077-86. PubMed ID: 15776492
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
[TBL] [Abstract][Full Text] [Related]
23. Cerebral blood volume quantification in a C6 tumor model using gadolinium per (3,6-anhydro) alpha-cyclodextrin as a new magnetic resonance imaging preclinical contrast agent.
Lahrech H; Perles-Barbacaru AT; Aous S; Le Bas JF; Debouzy JC; Gadelle A; Fries PH
J Cereb Blood Flow Metab; 2008 May; 28(5):1017-29. PubMed ID: 18183033
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibody modification with chelate-linked high-molecular-weight polymers: major increases in polyvalent cation binding without loss of antigen binding.
Torchilin VP; Klibanov AL; Nossiff ND; Slinkin MA; Strauss HW; Haber E; Smirnov VN; Khaw BA
Hybridoma; 1987 Jun; 6(3):229-40. PubMed ID: 3110049
[TBL] [Abstract][Full Text] [Related]
25. Carbamylation decreases the cytotoxicity but not the drug-carrier properties of polylysines.
Ekrami HM; Shen WC
J Drug Target; 1995; 2(6):469-75. PubMed ID: 7773608
[TBL] [Abstract][Full Text] [Related]
26. Affinity of binding of radiolabeled (125I) heparin and low molecular weight heparin fraction CY 222 to endothelium in culture.
Psuja P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(3):429-36. PubMed ID: 2444518
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and characterization of new low-molecular-weight lysine-conjugated Gd-DTPA contrast agents.
Laurent S; Burtea C; Vander Elst L; Muller RN
Contrast Media Mol Imaging; 2011; 6(4):229-35. PubMed ID: 21861283
[TBL] [Abstract][Full Text] [Related]
28. High-level conjugation of chelating agents onto immunoglobulins: use of an intermediary poly(L-lysine)-diethylenetriaminepentaacetic acid carrier.
Manabe Y; Longley C; Furmanski P
Biochim Biophys Acta; 1986 Oct; 883(3):460-7. PubMed ID: 3756213
[TBL] [Abstract][Full Text] [Related]
29. In vivo detection of c-Met expression in a rat C6 glioma model.
Towner RA; Smith N; Doblas S; Tesiram Y; Garteiser P; Saunders D; Cranford R; Silasi-Mansat R; Herlea O; Ivanciu L; Wu D; Lupu F
J Cell Mol Med; 2008; 12(1):174-86. PubMed ID: 18194445
[TBL] [Abstract][Full Text] [Related]
30. A cell- surface polymer reptation mechanism for tumor transendothelial transport of macromolecules.
Uzgiris EE
Technol Cancer Res Treat; 2008 Jun; 7(3):257-68. PubMed ID: 18473498
[TBL] [Abstract][Full Text] [Related]
31. The interaction of gadolinium complexes with isolated rat hepatocytes.
Thorstensen K; Romslo I
Biometals; 1995 Jan; 8(1):65-9. PubMed ID: 7865993
[TBL] [Abstract][Full Text] [Related]
32. Conformation and structure of polymeric contrast agents for medical imaging.
Uzgiris EE; Cline H; Moasser B; Grimmond B; Amaratunga M; Smith JF; Goddard G
Biomacromolecules; 2004; 5(1):54-61. PubMed ID: 14715008
[TBL] [Abstract][Full Text] [Related]
33. The role of molecular conformation on tumor uptake of polymeric contrast agents.
Uzgiris E
Invest Radiol; 2004 Mar; 39(3):131-7. PubMed ID: 15076004
[TBL] [Abstract][Full Text] [Related]
34. Biotinylated iodo-polylysine for pretargeted radiation delivery.
del Rosario RB; Wahl RL
J Nucl Med; 1993 Jul; 34(7):1147-51. PubMed ID: 8315493
[TBL] [Abstract][Full Text] [Related]
35. Accuracy of Tumor Perfusion Assessment in Rat C6 Gliomas Model with USPIO.
Yu XR; Cao BL; Li W; Tian Y; Du ZL
Open Med (Wars); 2019; 14():778-784. PubMed ID: 31737781
[TBL] [Abstract][Full Text] [Related]
36. Preference toward a polylysine enantiomer in inhibiting prions.
Jackson KS; Yeom J; Han Y; Bae Y; Ryou C
Amino Acids; 2013 Mar; 44(3):993-1000. PubMed ID: 23179088
[TBL] [Abstract][Full Text] [Related]
37. Proton relaxation enhancement by means of serum albumin and poly-L-lysine labeled with DTPA-Gd3+: relaxivities as a function of molecular weight and conjugation efficiency.
Spanoghe M; Lanens D; Dommisse R; Van der Linden A; Alderweireldt F
Magn Reson Imaging; 1992; 10(6):913-7. PubMed ID: 1334186
[TBL] [Abstract][Full Text] [Related]
38. Molecular MRI differentiation of VEGF receptor-2 levels in C6 and RG2 glioma models.
He T; Smith N; Saunders D; Pittman BP; Lerner M; Lightfoot S; Silasi-Mansat R; Lupu F; Towner RA
Am J Nucl Med Mol Imaging; 2013; 3(4):300-11. PubMed ID: 23901356
[TBL] [Abstract][Full Text] [Related]
39. Polylysine as a vehicle for extracellular matrix-targeted local drug delivery, providing high accumulation and long-term retention within the vascular wall.
Sakharov DV; Jie AF; Bekkers ME; Emeis JJ; Rijken DC
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):943-8. PubMed ID: 11397701
[TBL] [Abstract][Full Text] [Related]
40. Terminal-modified polylysine-based chelating polymers: highly efficient coupling to antibody with minimal loss in immunoreactivity.
Slinkin MA; Klibanov AL; Torchilin VP
Bioconjug Chem; 1991; 2(5):342-8. PubMed ID: 1790174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
